Recurrent hepatitis C in transplanted patients: More questions than answers

Digestive and Liver Disease

Volumn 35, Issue 1, 2003, Pages 2-6

  Bahr, M J ^a   Manns, M P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; HEPATITIS B ANTIBODY; INTERFERON; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GRAFT REJECTION; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; POSTOPERATIVE INFECTION; PROGNOSIS; RECURRENT INFECTION; REVIEW; VIRUS LOAD;

EID: 0037731408     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)00003-8     Document Type: Editorial

References (54)

1. Böker KHW, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, Bode U, Pichlmayr R, Manns MP. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997;25:203-10.
2. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, Fennessy S, Roberts JP, Ascher NL, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-22.
3. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, Neuwald P, Wilber J, Urdea M, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106:994-9.
4. Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann BC, Lau JY, Williams R. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996;110:167-77.
5. Pelletier SJ, Raymond DP, Crabtree TD, Berg CL, lezzoni JC, Hahn YS, Sawyer RG, Pruett TL. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. Hepatology 2000;32:418-26.
6. Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, Gown A, Frank I, Perkins JD, Carithers Jr. RL. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995;22:1-9.
7. Lim HL, Lau GK, Davis GL, Dolson DJ, Lau JY. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994;106:248-51.
8. Schluger LK, Sheiner PA, Thung SN, Lau JY, Mm A, Wolf DC, Fiel I, Zhang D, Gerber MA, Miller CM, Bodenheimer Jr. HC. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996;23:971-6.
9. Dickson RC, CaIdwell SH, Ishitani MB, Lau JY, Driscoll CJ, Stevenson WC, McCullough CS, Pruett TL. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 1996;61:701-5.
10. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, Reynes M, Brechot C, Bismuth H. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994;20:1137-43.
11. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-20.
12. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, Hoofnagle J. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823-30.
13. Feray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T, Loinaz C, Gigou M, Burra F, Barkholt L, Esteban R, Bizollon T, Lerut J, MineIIo-Franza A, Bernard PH, Nachbaur K, Botta-Fridlund D, Bismuth H, Schalm SW, Samuel D. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999;117:619-25.
14. Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, Markmann JF, Drazan KE, Halt C, Imagawa D, Goldstein LI, Martin F, Busuttil RW. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosupprèssion, and causes of retransplantation during an 8-year single-center experience. Ann Surg 1999;229:824-31, discussion 831-833.
15. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, Cordoba J, Herola A, Ascher N, Mir J, Berenguer J, Wright TL. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000;32:673-84.
16. Berenguer M, Prieto M, Rayon JM, Mora J, Pastor M, Ortiz V, Carrasco D, San Juan F, Burguena MD, Mir J, Berenguer J. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000;32:852-8.
17. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96.
18. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, Okamoto H, Bismuth H, Brechot C. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088-96.
19. Pageaux GP, Ducos J, Mondain AM, Castes V, Picot MC, Perrigault PF, Domergue J, Larrey D, Michel H. Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection. Liver Transpl Surg 1997;3:501-5.
20. Di Martino V, Brenot C, Samuel D, Saurini F, Paradis V, Reynes M, Bismuth H, Feray C. Influence of liver hepatitis C virus RNA and hepatitis C virus genotype on FAS-mediated apoptosis after liver transplantation for hepatitis C. Transplantation 2000;70:1390-6.
21. Berg T, Hopf U, Bechstein WO, Muller AR, Fukumoto T, Neuhaus R, Lobeck H, Neuhaus P. Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after arthotopic liver transplantation. Transplantation 1998;66:225-8.
22. Gayowski T, Singh N, Marina IR, Vargas H, Wagener M, Wan nstedt C, Morelli F, Laskus T, Fung JJ, Rakela J, Starzl TE. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997;64:422-6.
23. Vargas HE, Laskus T, Wang LF, Radkowski M, Poutous A, Lee R, Demetris JA, Gayowski T, Marina IR, Singh N, Dodson F, Casavilla A, Fung JJ, Rakela J. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 1998;4:22-7.
24. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds F, Roberts JP, Lake JR, Ascher NL, Wright TL. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996;24:1041-6.
25. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, Burgart L, Wiesner R, Kremers W, Rosen C, Charlton MR. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology 2000;32:1125-30.
26. Di Martino V, Saurini F, Samuel D, Gigou M, Dussaix E, Reynes M, Bismuth H, Feray C. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology 1997;26:1343-50.
27. Pelletier SJ, Raymond DP, Crabtree TD, lezzoni JC, Sawyer RG, Hahn YS, Pruett TL. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation. Hepatology 2000;32:375-81.
28. Gretch DR, Polyak SJ, Wilson JJ, Carithers Jr. RL, Perkins JD, Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996;70:7622-31.
29. Lawal Z, Petrik J, Wong VS, Alexander GJ, Allain JP. Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology 1997;228:107-11.
30. Yun Z, Barkholt L, Sonnerborg A. Dynamic analysis of hepatitis C virus polymorphism in patients with orthotopic liver transplantation. Transplantation 1997;64:170-2.
31. Pessoa MG, Bzowej N, Berenguer M, Phung Y, Kim M, Ferrell L, Hassoba H, Wright TL. Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation. Hepatology 1999;30:1513-20.
32. Doughty AL, Painter DM, McCaughan GW. Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus. J Hepatol 2000;32:126-34.
33. Huang EJ, Wright TL, Lake JR, Combs C, Ferrell LD. Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation. Hepatology 1996;23:396-404.
34. Feray C, Gigou M, Samuel D, Ducot B, Maisonneuve F, Reynes M, Bismuth A, Bismuth H. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med 1998;128:810-6.
35. Rosen HR, Chou S, Corless CL, Gretch DR, Flora KD, Boudousquie A, Orloff SL, Rabkin JM, Benner KG. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation 1997;64:721-6.
36. Humar A, Kumar D, Raboud J, Caliendo AM, Moussa G, Levy G, Mazzulli T. Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation. Am J Transplant 2002;2:46-466.
37. Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 2002;8:362-9.
38. Cotler SJ, Gaur LK, Gretch DR, Wile M, Strong DM, Bronner MP, Carithers Jr. RL, Emond MJ, Perkins JD, Nelson KA. Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. Tissue Antigens 1998;52:435-43.
39. Manez R, Mateo R, Tabasco J, Kusne S, Starzl TE, Duquesnoy RJ. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995;59:640-2.
40. Belli LS, Zavaglia C, Alberti AB, Poli F, Rondinara G, Silini E, Taioli Carl E, de Carlis L, Scalamogna M, Forti D, Pinzello G, Ideo G. Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation. Hepatology 2000;31:1345-50.
41. Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, Bodenheimer H, Emre S, Miller CM. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995;21:30-4.
42. Berenguer M, Prieto M, Cordoba J, Rayon JM, Carrasco D, Olaso V, San-Juan F, Gobernado M, Mir J, Berenguer J. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. J Hepatol 1998;28:756-63.
43. Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997;92:1453-7.
44. Berenguer M, Lopez-Labrador FX, Greenberg HB, Wright TL. Hepatitis C virus and the host: An imbalance induced by immunosuppression? Hepatology 2000;32:433-5.
45. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002;51:248-52.
46. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002;36:202-10.
47. Sheiner PA, Boros F, Klion FM, Thung SN, Schluger LK, Lau JY, Mar E, Bodian C, Guy SR, Schwartz ME, Emre S, Bodenheimer Jr. HC, Miller CM. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998;28:831-8.
48. Singh N, Gayowski T, Wannstedt CF, Shakil AO, Wagener MM, Fung JJ, Marino IR. Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation 1998;65:82-6.
49. Mazzaferro V, Tagger A, Schiavo M, Regalia E, Pulvirenti A, Ribero ML, Coppa J, Romito R, Burgoa L, Zucchini N, Urbanek T, Bonino F.Pr F. Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment. Transplant Proc 2001;33:1355-7.
50. Narayanan Menon KV, Poterucha JJ, El-Amin OM, Burgart U, Kremers WK, Rosen CB, Wiesner RH, Charlton M. Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficacy. Liver Transpl 2002;8:623-9.
51. Kornberg A, Hommann M, Tannapfel A, Wagner T, Grube T, Schotte U, Voigt R, Scheele J. Long-term combination of interferon alfa-2b and ribavirin for hepatitis C recurrence in liver transplant patients. Am J Transplant 2001;1:350-5.
52. Gopal DV, Rabkin JM, Berk BS, Corless CL, Chou S, Olyaei A, Orloff SL, Rosen HR. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver Transpl 2001;7:181-90.
53. De Vera ME, Smallwood GA, Rosado K, Davis L, Martinez E, Sharma S, Stieber AC, Heffron TG. Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation. Transplantation 2001;71:678-86.
54. Ong JP, Younossi ZM, Gramlich T, Goodman Z, Mayes J, Sarbah S, YenLieberman B. Interferon alpha 2B and ribavirin in severe recurrent cholestatic hepatitis C. Transplantation 2001;71:1486-7.